Anti-VEGFA antibody [EP1176Y] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
5
(1 Review)
|
(16 Publications)
Rabbit Recombinant Monoclonal VEGFA antibody. Carrier free. Suitable for ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Mouse, Human samples. Cited in 16 publications.
View Alternative Names
VEGF, VEGFA, L-VEGF, Vascular permeability factor, VPF
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)
Clone EP1176Y (ab185238) has been successfully conjugated by Abcam. This image was generated using Anti-VEGFA antibody [EP1176Y] (Alexa Fluor® 488). Please refer to ab206886 for protocol details.
ab206886 staining VEGF in HeLa (Human epithelial cell line from cervix adenocarcinoma) cells. The cells were fixed with 4% formaldehyde (10 minutes), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1 hour. The cells were then incubated overnight at +4°C with ab206886 at 1/1000 dilution (shown in green) and ab195889, Mouse monoclonal to alpha Tubulin (Alexa Fluor® 594), at 1/250 dilution (shown in red). Nuclear DNA was labelled with DAPI (shown in blue).
Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)
This data was developed using ab52917, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of formalin fixed paraffin embedded human kidney labelling VEGFA with ab52917 at a concentration of 2µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a ChromoMap DAB IHC Detection Kit followed by anti rabbit HQ and anti HQ HRP detection. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 64mins.
ab52917 Anti-VEGFA antibody [EP1176Y] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.
Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human kidney tissue sections labeling VEGFA with Purified ab52917 at 1 : 100 dilution (2.96 µg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab52917).
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)
Immunohistochemistry (Paraffin-embedded sections) analysis of Human kidney tissue labeling VEGF with ab185238 at 1/250. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9.0. Anti-rabbit IgG H&L (HRP) (ab97051) was used as the secondary antibody. Counterstained with Hematoxylin.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab52917).
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)
Clone EP1176Y (ab185238) has been successfully conjugated by Abcam. This image was generated using Anti-VEGFA antibody [EP1176Y] (PE). Please refer to ab209439 for protocol details.
Overlay histogram showing HeLa cells stained with ab209439 (red line). The cells were fixed with 4% formaldehyde (10 min) and then permeabilized with 90% methanol at -20°C for 15 min. The cells were then incubated in 1x PBS / 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (ab209439, 1/2500 dilution) for 30 min at 22°C.Isotype control antibody (black line) was rabbit IgG (monoclonal) Phycoerythrin (ab209478) used at the same concentration and conditions as the primary antibody. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20 mW Solid State Blue Laser (488nm) and 585/40 bandpass filter.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)
Clone EP1176Y (ab185238) has been successfully conjugated by Abcam. This image was generated using Anti-VEGFA antibody [EP1176Y] (Alexa Fluor® 647). Please refer to ab206887 for protocol details.
ab206887 staining VEGF in HeLa cells. The cells were fixed with 4% formaldehyde (10 min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated overnight at +4°C with ab206887 at 1/100 dilution (shown in red) and ab195887, Mouse monoclonal to alpha Tubulin (Alexa Fluor® 488), at 1/250 dilution (shown in green). Nuclear DNA was labelled with DAPI (shown in blue).
Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)
Intracellular Flow Cytometry analysis of NIH/3T3 (Mouse embryonic fibroblast) cells labeling VEGFA with purified ab52917 at 1/30 dilution (10 μg/ml) (red). Cells were fixed with 4% Paraformaldehyde. A Goat anti rabbit IgG (Alexa Fluor® 488) secondary antibody was used at 1/2000 dilution. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab52917).
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)
Purified ab52917 staining VEGF in NIH3T3 cells. The cells were fixed with 4% formaldehyde (10min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked in 1% BSA/10% normal goat serum/0.3M glycine in 0.1%PBS-Tween for 1h. The cells were then incubated with purified ab52917 at 5μg/ml and ab195884, at 1/250 dilution, overnight at +4°C, followed by a further incubation at room temperature for 1h with an Goat anti-Rabbit Alexa Fluor 488 secondary (ab150081) at 2 μg/ml (shown in green). Nuclear DNA was labelled in blue with DAPI.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab52917).
- IHC-P
AbReview38570****
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)
Unpurified ab52917 staining VEGF in Mouse kidney tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with paraformaldehyde, permeabilized with 0.3% Triton X-100 and blocked with 5% serum for 45 minutes at 25°C. Samples were incubated with primary antibody (1/400 in 4% BSA + 5% serum in PBST) for 14 hours at 4°C. An Alexa Fluor® 546-conjugated Donkey anti-rabbit IgG polyclonal (1/300) was used as the secondary antibody.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab52917).
This image is courtesy of an anonymous Abreview.
Related conjugates and formulations (6)
-
Anti-VEGFA antibody [EP1176Y] - C-terminal
-
578 PE
PE Anti-VEGFA antibody [EP1176Y]
-
Biotin Anti-VEGFA antibody [EP1176Y]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-VEGFA antibody [EP1176Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-VEGFA antibody [EP1176Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-VEGFA antibody [EP1176Y]
Reactivity data
Product details
ab185238 is the carrier-free version of ab52917.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
VEGFA functions by promoting the proliferation and migration of vascular endothelial cells. It operates both as a homodimer and as part of complex signaling cascades interacting with VEGF receptors on cell surfaces to trigger downstream signals for angiogenesis. This includes endothelial cell growth migration and the new blood vessel formation process. VEGFA's activity is important for physiological processes such as wound healing and embryonic development and it also contributes to pathological conditions through its unregulated expression in diseases.
Pathways
Many processes involve VEGFA including the PI3K/AKT pathway and the MAPK/ERK pathway. These pathways regulate cell survival growth and differentiation. Other proteins like PLGF (placenta growth factor) and VEGFB often accompany VEGFA in these pathways aiding in distinct but overlapping roles. These interactions are transmitted through binding to VEGF receptors such as VEGFR-1 and VEGFR-2 subsequently activating various signaling cascades necessary for cellular and tissue homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (16)
Recent publications for all applications. Explore the full list and refine your search
iScience 28:112862 PubMed40612503
2025
Applications
Unspecified application
Species
Unspecified reactive species
European journal of dentistry 19:531-539 PubMed39657933
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 12: PubMed39200306
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell 42:1217-1238.e19 PubMed38981438
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 24:195 PubMed38835070
2024
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 10:eadi5501 PubMed38354243
2024
Applications
Unspecified application
Species
Unspecified reactive species
Physiological reports 11: PubMed37962017
2023
Applications
Unspecified application
Species
Unspecified reactive species
Gene 878:147578 PubMed37336277
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 19:675-690 PubMed36632459
2023
Applications
Unspecified application
Species
Unspecified reactive species
Stem cells international 2022:9806887 PubMed36199627
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com